Back when the share price sky rocketed due to speculation of a partnership with Sarepta, there was absolute euphoria around here and Akki was one of the few to point out that maybe their capital raise wasn't for a partnership. He/she was absolutely roasted for this but turned out to be correct.
Akki again makes a solid argument that just because Clary worked at Pfizer doesn't mean a deal is imminent. That is not a negative comment, it provides a different perspective.
I am here to have my own ideas challenged and Akki does just that. I will go as far to say that Akki is one of a handful of posters who I bother to even read their post these days because of the mess this place has become.
PER Price at posting:
8.4¢ Sentiment: None Disclosure: Held
